Ads
related to: advanced ovarian cancer treatment guidelines- Treatment Effectiveness
Read About How Treatment Works And
Its Benefits And Risks In Patients.
- About PARP Inhibitors
Learn About How Treatment Works.
Learn About Maintenance Therapy.
- Talk To Your Doctor
Get Resources To Help Stay Informed
To Make Your Conversation Easier.
- Safety And Side Effects
Read Important Safety Information.
Learn More About A Treatment.
- First-Line Maintenance
Learn About First-Line Treatment.
Download Helpful Resources & Info.
- Tablet Dosing Info
Learn About Tablet Dosing For
An Ovarian Cancer Treatment.
- Treatment Effectiveness
Search results
Results From The WOW.Com Content Network
In a Phase II study on 119 patients with advanced ovarian cancer in which the standard therapies had already been ineffective, treatment with abagovomab led to a prolongation of survival time (23.4 months compared to 4.9 months) in those patients who responded to the vaccination, i.e. those in whom the formation of antibodies against the tumour was proven (almost 70% of patients).
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults.It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair.
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. [1] In this procedure, warmed anti-cancer medications are infused and circulated in the peritoneal cavity (abdomen) for a short period of time.
Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or walls of the abdomen, and have received one to three prior lines of treatment, according ...
It has been recommended as part of the treatment plan for any person with advanced ovarian cancer or patients with significant symptoms. [125] In platinum-refractory and platinum-resistant cases, other palliative chemotherapy is the main treatment.
As ovarian cancer is rarely symptomatic until an advanced stage, [42] regular pre-emptive screening is a particularly important tool for avoiding the late stage at which most patients present. However, A 2011 US study found that transvaginal ultrasound and cancer marker CA125 screening did not reduce ovarian cancer mortality. [43]
Ads
related to: advanced ovarian cancer treatment guidelines